Lin, T., Izumi, K., Lee, S. O., Lin, W., Yeh, S., & Chang, C. (2013). Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling. Nature Publishing Group.

Lin, T-H, K. Izumi, S O. Lee, W-J Lin, S. Yeh, and C. Chang. Anti-androgen Receptor ASC-J9 Versus Anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) Leads to Opposite Effects On Prostate Cancer Metastasis Via Differential Modulation of Macrophage Infiltration and STAT3-CCL2 Signaling. Nature Publishing Group, 2013.

Lin, T-H, et al. Anti-androgen Receptor ASC-J9 Versus Anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) Leads to Opposite Effects On Prostate Cancer Metastasis Via Differential Modulation of Macrophage Infiltration and STAT3-CCL2 Signaling. Nature Publishing Group, 2013.